May 25, 2019
2 min watch
Save

VIDEO: Bimatoprost SR shows long-term IOP lowering

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

SAN DIEGO — At the American Society of Cataract and Refractive Surgery meeting, E. Randy Craven, MD, discusses a study looking at the long-term IOP-lowering effects of Bimatoprost SR (Allergan) in patients with glaucoma.